The Headquarter of Hualida Biotech is situated in Hualida BioPark, Tianjin TEDA, China, covering a land of 76,000 square meters with construction area of 30,000 square meters that complies with International GMP Standards. Hualida Biotech is a manufacturing-base enterprise involved in researching, development and marketing of genetic recombinant medicine, highly purified protein, anti-virus and anti-tumor chemicals and natural products.

Hualida Biotech, founded in 1992, is a leading enterprise in the industrialization of recombinant products in China with the registered capital of 29.514 millions USD, Shareholdings are divided into 60% and 40% owned by TEVA Pharmaceutical Group of Israel and Zhongxin Pharmaceutical group of China respectively. Hualida Biotech has 140 employees involved in drug research, development, production and management; we have established a sophisticated marketing and service network with about 300 sales representatives widely engaged in academic promotion, lecturing and market exploitation by means of setting up branches all over the main regions in China.

We are all proud of the even growth of Hualida Biotech in the field of biopharmaceuticals in China. Since 2002 when Hualida Biotech began to take the top position in the domestic interferon market and exported products to many districts in Southeast Asia, South Asia and etc., we has become the largest manufacturing base of human recombinant interferon alpha-2b in China.

"Bring happiness to the people all over the world" is our earnest wishes and permanent pursuance. We believe that by attaching importance to the "Human oriented, Teamwork, Practicality & innovation, and Excellence" as the enterprise philosophy, and guided by the quality policy of "Providing users with medicines of the highest quality in the world", we shall do our best to make you satisfied with our products and service, and to bring you and your family a more healthy and harmonious life.